Juan C. Diaz, MD, explained why conduction pacing may be the way of the future.

A new retrospective study from the Mayo Clinic focused on patients with no other need for anticoagulation.

The new investments were announced as the company continues developing its CLAAS device for sealing the LAA during LAAO procedures.

The FDA has labeled this as a Class I recall, which means using these devices can lead to significant injuries, including death.

Findings from the SOLVE-CRT study were presented to attendees at Heart Rhythm 2023. "Our results showed the study was safe, effective and feasible," Singh said. 

The two companies first started collaborating on diabetes technology in 2021. The acquisition is not yet final, but Novo Nordisk now holds the exclusive negotiation rights.

The DurAVR transcatheter heart valve, developed by Minnesota-based Anteris Technologies, was designed to move and perform like a healthy, pre-disease native aortic valve.

A new systematic review and meta-analysis of 30 RCTs highlighted numerous benefits associated with vegetarian and vegan diets. Combining a plant-based diet with statin therapy, one researcher noted, could result "in an even larger beneficial effect.”

H.R. 3561 also would apply to groups owned by physicians, hospitals, insurers, or venture capital firms, who could face fines of $2M for failing to comply. 

The audit revealed that Medicare overpaid by approximately $22.5 million due to incorrect place-of-service coding completed by practitioners.